Skip to main content
SpringerLink
Log in

Stem Cell Therapy Trials: A Call for Standardization

  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

There are currently 25 new clinical cellular therapy trials in progress for cardiovascular disease in the US, and a similar number ongoing in Europe. The lack of standardization in cell isolation, preparation, storage, and time and localization of delivery, present clear hurdles to this growing field. This emphasizes the need for an organized task force to work closely with the FDA to agree upon standardized methods with the end result being improvements in patient care and enhanced knowledge in the field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wollert, K. C., & Drexler, H. (2005). Clinical applications of stem cells for the heart. Circulation Research, 96, 151–163.

    Article  PubMed  CAS  Google Scholar 

  2. Dimmeler, S., Burchfield, J., & Zeiher, A. M. (2008). Cell-based therapy of myocardial infarction. Arteriosclerosis, Thrombosis & Vascular Biology, 28(2), 208–216 Feb.

    Article  CAS  Google Scholar 

  3. Dimmeler, S., Zeiher, A. M., & Schneider, M. E. (2005). Unchain my heart: the scientific foundations of cardiac repair. Journal of Clinical Investigation, 115, 572–583.

    PubMed  CAS  Google Scholar 

  4. Orlick, D., Kajstura, J., Chimenti, S., & Anversa, P. (2001). Bone marrow cells regenerate infracted myocardium. Nature, 410, 701–705.

    Article  Google Scholar 

  5. Taylor, D. A., Atkins, B. Z., Hungspreugs, P., Jones, T. R., & Reedy, M. C. (1998). Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nature Medicine, 4, 929–933.

    Article  PubMed  CAS  Google Scholar 

  6. Oettgen, P. (2006). Stem cell therapy: need for optimization of efficacy and safety monitoring. Circulation, 114, 353–358.

    Article  PubMed  Google Scholar 

  7. Boyle, A. J., Schulman, S. P., & Hare, J. M. (2006). Stem cell therapy for cardiac repair: ready for the next step? Circulation, 114, 339–352.

    Article  PubMed  Google Scholar 

  8. Rosenzweig, A. (2006). Cardiac cell therapy—mixed results from mixed cells. New England Journal of Medicine, 355(12), 1274–1277.

    Article  PubMed  CAS  Google Scholar 

  9. Dimmeler, S. (2006). Viewpoint: stem cells in cardiology. Circulation, 113(18), f69–70.

    PubMed  Google Scholar 

  10. Gnecchi, M., He, H., Noiseux, N., Ingwall, J., & Dzau, V. (2006). Evidence supporting paracrine hypothesis for Akt-modified mesenchymal cell-mediated cardiac functional improvement. FASEB, 20, 661–669.

    Article  CAS  Google Scholar 

  11. Update on Clinical Trials in Cell Therapy for CV Disease. http://www.clinicaltrials.com

  12. Perin, E. C., & Lopez, J. (2006). Methods of stem cell delivery in cardiac diseases. Nature Clinical Practice Cardiovascular Medicine, 3(Suppl 1), S110–S113 Mar.

    Article  PubMed  Google Scholar 

  13. Assmus, B., Honold, J., Schachinger, V., Britten, M. B., Fischer-Rasokat, U., Lehmann, R., et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. New England Journal of Medicine, 355(12), 1222–1232 Sep 21.

    Article  PubMed  CAS  Google Scholar 

  14. Schachinger, V., Erbs, S., Elsasser, A., Haberbosch, W., Hambrecht, R., Holschermann, H., et al. (2006). REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. New England Journal of Medicine, 355(12), 1210–1221 Sep 21.

    Article  PubMed  CAS  Google Scholar 

  15. Seeger, F. H., Tonn, T., Krzossok, N., Zeiher, A. M., & Dimmeler, S. (2007). Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. European Heart Journal, 28(6), 766–772 Mar.

    Article  PubMed  Google Scholar 

  16. Wollert, M. K. C., Meyer, G. P., Drexler, H., Hertenstein, B., Ganser, A., Rudinger, W., et al. (2007). Good manufacturing practice-compliant validation and preparation of BM cells for the therapy of acute myocardial infarction. Cytotherapy, 9(1), 35–43.

    Article  PubMed  Google Scholar 

  17. Dib, N., & Dinsmore, R. (2008). Methods of delivery of cell therapy for cardiovascular disease. JCTR (in press).

  18. Kissel, C. K., Lehmann, R., Assmus, B., Aicher, A., Honold, J., Fischer-Rasokat, U., et al. (2007). Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. Journal of the American College of Cardiology, 49(24), 2341–2349 Jun 19.

    Article  PubMed  Google Scholar 

  19. Hare, J. (2007). Cardiovascular regeneration and stem cell therapy. Circulation, 116(7), e144–145.

    Article  Google Scholar 

  20. Hare, J. M., & Henry, T. (2007). Safety and efficacy of intravenous delivery of allogeneic mesenchymal stem cells in acute MI. Presented at Am Heart Assoc Scientific Session.

  21. Dohmann, H. F., Perin, E. C., Takiya, C. M., Silva, G. V., Silva, S. A., Sousa, A. L., et al. (2005). Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation, 112(4), 521–526 Jul 26.

    Article  PubMed  Google Scholar 

  22. Deng, M. C., Edwards, L. B., Hertz, M. I., Rowe, A. W., Keck, B. M., Kormos, R., et al. (2005). International Society for Heart and Lung Transplantation. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report—2005. Journal of Heart & Lung Transplantation, 24(9), 1182–1187 Sep.

    Article  Google Scholar 

  23. Bartunek, J., Dimmeler, S., Drexler, H., Fernandez-Aviles, F., Galinanes, M., Janssens, S., et al. (2006). Task force of the European Society of Cardiology. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. European Heart Journal, 27(11), 1338–1340 Jun.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology, Washington Hospital Center, 110 Irving Street, N.W., Room 1E-11, Washington, D.C., 20010, USA

    Leslie W. Miller

  2. Cardiology, Georgetown University Hospital, Washington, D.C., USA

    Leslie W. Miller

Authors
  1. Leslie W. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leslie W. Miller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miller, L.W. Stem Cell Therapy Trials: A Call for Standardization. J. of Cardiovasc. Trans. Res. 1, 185–187 (2008). https://doi.org/10.1007/s12265-008-9042-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-008-9042-0

Keywords

Search

Navigation